Atlas Trials

Dapagliflozin Plus Pioglitazone in T1DM

Clinical trial NCT03878459 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03878459
Sponsor
The University of Texas Health Science Center at San Antonio
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2019-08-08
Primary completion
2026-03-15
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.